Celldex Therapeutics, Inc

CLDXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
28.62 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
28.56
↘ 0.06 (0.21%)
POST MARKET (AS OF 06:59 PM EDT)
Post Market
AS OF 06:59 PM EDT
28.56
↘ 0.06 (0.21%)
🔴Market: CLOSED
Open?$29.83
High?$30.05
Low?$28.46
Prev. Close?$28.62
Volume?1.3M
Avg. Volume?740.2K
VWAP?$29.11
Rel. Volume?1.72x
Bid / Ask
Bid?$26.80 × 100
Ask?$32.97 × 100
Spread?$6.17
Midpoint?$29.88
Valuation & Ratios
Market Cap?2.2B
Shares Out?78.5M
Float?60.5M
Float %?90.9%
P/E Ratio?N/A
P/B Ratio?4.92
EPS?-$3.61
Dividend?0.00%
Ex-Dividend?N/A

Shares of Celldex Therapeutics, Inc (CLDX) are trading at $28.64. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
198
Market Cap
2.2B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.celldex.com
Listed
1986-05-15
Address
53 FRONTAGE ROAD
HAMPTON, NJ 08827
Phone: 908-200-7500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
18
Short Sent.?
53
Piotroski F-Score?1/9Weak
Altman Z-Score?18.28Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?11.78%High
Short Interest?7.1M
Days to Cover?10.1
Free Float60.5M
Avg Daily Volume708.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?8.92Strong
Quick Ratio?8.92Strong
Cash Ratio?0.69Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
37
4.92FAIR▾
P/S?
Peers
100
S&P
3
2,594.05HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
2,552.79HIGH▾
Returns & Efficiency
ROE?
S&P
3
-62.2%WEAK▾
ROA?
S&P
3
-55.5%WEAK▾
Cash Flow & Enterprise
FCF?$-226249000
Enterprise Value?$2.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist